Modulation of radiosensitivity in Chinese hamster lung fibroblasts by cisplatin
Authors:
- 1 May 2008
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 86 (5) , 257-263
Abstract
The effects of cisplatin exposure time, concentration, and irradiation sequence on the sensitivity of Chinese hamster lung fibroblasts (V79) to γ-ray exposure were examined. Based on clonogenic cell survival, the cisplatin concentrations corresponding to 50% cell survival (EC50) for exposure times of 1 h to 7 days followed a 2-phase exponential decay and ranged from 28.26 ± 3.32 to 1.53 ± 0.24 μmol/L, respectively. When cells were treated at EC50 for exposures of less than 4 h and irradiated immediately, cisplatin inhibited the effect of radiation. Exposures of 4–6 h did not affect radiosensitivity. For exposures of 8–12 h, radiosensitization was observed, which disappeared at 14 h and reappeared for much longer cisplatin treatments. At the lowest achievable EC50 (1.53 μmol/L), radiosensitization was observed if irradiation was delayed for 1–8 h. This enhancement in radiosensitivity disappeared for irradiation delays of 10–12 h, but reappeared when irradiation was delayed for 14–18 h. These data demonstrate that the mode of interaction between cisplatin and γ-irradiation depends on the concentration and exposure time of cisplatin, as well as on the timing of irradiation after cisplatin administration. Consideration of changes in cell cycle kinetics may contribute to the improvement of treatment outcomes in adjuvant chemoradiotherapy involving cisplatin.Keywords
This publication has 49 references indexed in Scilit:
- Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapyGynecologic Oncology, 2007
- Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancerLung Cancer, 2006
- Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: A pharmacology-guided scheduleInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancerLung Cancer, 2006
- Cell death induced in a human glioblastoma cell line by p(65)+Be neutrons combined with cisplatinLife Sciences, 2006
- Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancerLung Cancer, 2006
- Early stage infradiaphragmatic Hodgkin's disease: results of radiotherapy and review of the literatureRadiotherapy and Oncology, 2003
- The management of adult aggressive non-Hodgkin’s lymphomasCritical Reviews in Oncology/Hematology, 2000
- Combination of cisplatin and radiation in cell culture: Effect of duration of exposure to drug and timing of irradiationInternational Journal of Cancer, 1998
- An interaction of cis platin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitroInternational Journal of Radiation Biology, 1996